| BSE: 512529 | Sector: Health care |
| NSE: SEQUENT | ISIN Code: INE807F01027 |
| BSE 00:00 | 18 Jun | 64.10 |
0 (0.00%) |
OPEN
63.80 |
HIGH
68.70 |
LOW
63.50 |
| NSE 00:00 | 18 Jun | 63.95 |
0.05 (0.08%) |
OPEN
65.00 |
HIGH
69.70 |
LOW
63.50 |
| OPEN | 63.80 |
| PREVIOUS CLOSE | 64.10 |
| VOLUME | 93458 |
| 52-Week high | 123.64 |
| 52-Week low | 44.65 |
| P/E | 82.18 |
| Mkt Cap.(Rs cr) | 1,562 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Visistha Traders & Finance Ltd, has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12, 2003. ...> More
| COMPANY INFORMATION | |||||||
| Chairman : | Gopakumar G Nair | ||||||
| Independent Director : | Kausalya Santhanam | ||||||
| Managing Director & CEO : | Manish Gupta | ||||||
| Independent Director : | Narendra Mairpady | ||||||
| Non Executive Director : | S Devendra | ||||||
| Non Executive Director : | K E C Raja Kumar | ||||||
| Joint Managing Director : | Sharat Narasapur | ||||||
| Company Secretary : | Krupesh Mehta | ||||||
| AUDITOR : | Deloitte Haskins & Sells | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| 301 Dosti Pinnacle 3rd Floor, Plot E7 Road No 22 Wagle Indl,Thane,Maharashtra-400604 | |||||||
| Ph : 91-022-41114777 | |||||||
| WEBSITE : http://www.pidrugs.com | |||||||
| E-mail : pidsecretarial@yahoo.co.in | |||||||
